Search Results 1881-1890 of 18824 for Relapse

  1. A Study of Axatilimab at 3 Different Doses in Patients With Chronic Graft Versus Host Disease (cGVHD) - Mayo Clinic

    Has acute GVHD without manifestations of cGVHD. 2. Any evidence (histologic, cytogenetic, molecular, hematologic, or mixed) of relapse of the underlying ...

  2. Science Saturday: Quest to unmask an elusive immune cancer - Mayo Clinic News Network

    What's the most effective treatment for me? “Sometimes, the lymphoma could be controlled with chemotherapy, but other patients relapsed repeatedly. Why? We just ...

  3. A Study of STX-0712 in Patients with Advanced Hematologic Malignancies - Mayo Clinic

    Relapsed/refractory monocytic or monocytic predominant AML. Monocytic predominant AML is defined as ≥50% monocytes and/or monocytic precursors ...

  4. Hematology - Clinical trials

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

  5. Hematology - Clinical trials

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

  6. JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation - Mayo Clinic

    ... relapsed or refractory solid tumors with KRAS G12C mutation. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

  7. 10 ways to control high blood pressure without medication - Mayo Clinic News Network

    By making these 10 lifestyle changes, you can lower your blood pressure and reduce your risk of heart disease. This article is written by Mayo Clinic Staff.

  8. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    PHASE I: Histological confirmation of relapsed (recurrent after previous therapy[ies]) or refractory (no response to previous therapy[ies]) B-cell NHL; note ...

  9. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

    ... relapsed/refractory large B-cell lymphoma. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  10. Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome - Mayo Clinic

    All MDS subjects are required to have failed to respond, relapsed after an initial response, or be unable to tolerate hypomethylating agents 5-azacitidine ...